Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Respiratory Aspiration × Inhalation × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 2 Respiratory Aspiration 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Surgical Procedures, Operative 1 Radiotherapy 1 Radiosurgery 1 One-Lung Ventilation 1 Inhalation 1 Diclofenac 1 Cryosurgery 1 Anterior Temporal Lobectomy 1 Anesthesia, General 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06896890 2025-03-26

Cisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung Cancer

Inhatarget Therapeutics

Phase 1/2 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Respiratory Aspiration

Data powered by HemOnc (CC BY 4.0) Colophon ⚡